Drug Profile
Salmeterol/fluticasone propionate - Evofem Biosciences
Alternative Names: Fluticasone propionate/salmeterol - Evofem Biosciences; LIPO-102; Salmeterol xinafoate/fluticasone propionate - Evofem Biosciences; Salmeterol xinafoate/fluticasone propionate - LitheraLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Lithera
- Developer Evofem Biosciences; Neothetics
- Class Androstadienes; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Phenethylamines; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists; Lipocortin synthesis agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Exophthalmos
- Discontinued Subcutaneous fat disorders